Head-to-head · WeighScore
Sesame Care vs WellMedr
By GLP-1 ScorecardUpdated
Score comparison
Sesame Care has the higher recorded score — 87.8/100 to 63.2/100.
Sesame Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Choose a provider for Wegovy, Zepbound and oral GLP-1 options through Sesame; care and medication are billed separately, and the annual care headline needs comparison with the shorter plan.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Sesame Care | WellMedr |
|---|---|---|
| WeighScore | 87.8/100 | 63.2/100 |
| Grade | B+ | C |
| Site position | #2 | #221 |
| Semaglutide | Brand Wegovy pill from $149/mo at 1.5/4 mg; $299 at 9/25 mg, plus required care: from $59/mo on annual subscription or $99 every 28 days (confirm billing) | Advertised from $49/month; selected upfront total, plan term and renewal amount need confirmation |
| Tirzepatide | Brand Zepbound vials from $299/mo at 2.5 mg; higher doses cost more and KwikPen pages conflict, plus required care (confirm selected product and billing) | Advertised from $89/month; selected upfront total, plan term and renewal amount need confirmation |
| Coverage | U.S. marketplace; provider and treatment availability varies; confirm your state | General service page lists all 50 states, DC, Puerto Rico and Guam; exact medication, clinical eligibility and pharmacy fulfillment remain conditional |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #2 · B+
Strengths
- Provider choice with advertised video visits, follow-ups and continuing messaging
- Branded injection and oral options are described, subject to prescribing, dose, insurance and pharmacy availability
- Quest lab costs are included except in nine named states; alternative lab coverage requires confirmation
- The current semaglutide page explicitly distinguishes branded products from compounded semaglutide, which it says is currently unavailable
What to consider
- The $59 care headline requires an annual subscription and excludes medication; provider-specific care rates may be higher
- Ordinary care is called monthly but also billed every 28 days; longer-term savings arithmetic needs confirmation
- Program refund wording differs from newer terms describing multi-month repricing and a 48-hour renewal notice
- Drug prices depend on dose and promotion; official KwikPen and Foundayo displays contain discrepancies
- The selected clinician, medical practice and dispensing pharmacy were not established by this review
Site position #221 · C
Strengths
- Publishes separate descriptions of 21-day billing and fully prepaid three-, six- and twelve-month plans
- The refund policy provides detailed renewal and unused-prepayment rules, although important provisions conflict with the Terms
- Current documents name possible pharmacy partners, including Logos, Emerald and Center City; the assigned facility still needs confirmation
- The safety page distinguishes compounded preparations from FDA-approved products rather than treating shared ingredients as proof of equivalence
What to consider
- Starting $49 and $89 advertisements do not establish the total due today, renewal amount or usable prescription supply; confirm whether membership and medication are separate charges
- Four-week shipping is not the billing calendar; the separately described 21-day plan can generate more frequent charges
- The refund policy accepts cancellation before a charge is submitted, while the Terms require two days’ notice and allow early renewal processing
- Unused-prepayment allocation in the refund policy conflicts with discretionary partial refunds, medication-plan cancellation windows and a nonrefundable first membership month in the Terms; no legal priority is established
- The ninety-day results-refund promise conflicts with policy language denying a results guarantee; clarify the selected written agreement
- The current directory does not establish an available oral or microdose GLP-1 purchase; the homepage labels microdose Coming soon
- Current documents do not identify the assigned clinical practice, clinician, dispenser or physical compounder; general service coverage does not guarantee every preparation
Featured provider
Sesame Care
Sesame Care scores 87.8/100 (B+). Choose a provider for Wegovy, Zepbound and oral GLP-1 options through Sesame; care and medication are billed separately, and the annual care headline needs comparison with the shorter plan.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.